1. The pharmacokinetics of the beta 2-adrenocepter agonist, tulobuterol given transdermally and by inhalation;Uematsu;Eur. J. Clin. Pharmacol.,1993
2. Clinical evaluation of a transdermal therapeutic system of β2-agonist tulobuterol in patients with mild or moderate persistent bronchial asthma;Horiguchi;Arzneinittelforschung,2004
3. Pharmacokinetics and pharmacodynamics of the tulobuterol patch, HN-078, in childhood asthma;Iikura;Ann. Allergy Asthma Immunol.,1995
4. Clinical evaluation of tulobuterol patch in patients with mild or moderate persistent bronchial asthma—effects of long-term treatment on airway inflammation and hypersensitivity;Horiguchi;Nihon Kokyuki Gakkai Zasshi,2004
5. Development of transdermal formulation of tulobuterol for the treatment of bronchial asthma;Kato;Yakugaku Zasshi,2002